Guardian Pharmacy Services (GRDN) said late Tuesday it has launched an underwritten public offering of 7.5 million Class A shares, with Raymond James as lead bookrunning manager.
The issue comprises of about 6.1 million shares from some stockholders and around 1.4 million newly issued shares as part of a non-dilutive "synthetic secondary" transaction, the firm said.
The company said the offering is considered non-dilutive as it plans to use the proceeds to repurchase from some stockholders a number of shares equal to the number of shares Guardian sold in the offering.
The selling stockholders plan to grant underwriters a 30-day option to purchase up to about 1.1 million additional shares.
Shares were down over 6% in after-hours trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.